TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: DBP response to CPT
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: SBP response to CPT
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Successful induction of delivery
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Frequency of Sectio Caesarea
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Onset of uterine contractions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Pregnancy and childbirth outcomes
Primary endpoint: Work Ability Index score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in HARS scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Improvement in PGWBI scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: virological failure rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HbA₁(c) level decrease
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Improvement in metabolic risk factors
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: asthma attack
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Extubation times
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Fasting glycaemia levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: in-segment LLL (mm)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Improvement in BBS score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality of self-reported postural balance
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Influence of postural balance impairment on activities of daily living
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Depressive symptoms response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: tongue elevation strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: tongue posture at rest
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: tongue position during swallowing of solid food
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: MCID in functional independence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Vocabulary size
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: frequency of stool output
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: volume of stool
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: intake of ORS
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Number of seizures per week
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Questionnaire response rates
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Cost per participant
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Self-monitoring of blood glucose (SMBG) accuracy and convenience
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Improvement in clinical periodontal parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: GCF IL-6 concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Blunted nocturnal decline in systolic BP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Blunted nocturnal decline in diastolic BP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Blunted nocturnal decline in HR
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Prostate tissue concentrations of genistein and daidzein
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Detectable plasma equol concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC of lovastatin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: t(1/2) of lovastatin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: tmax of lovastatin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: TVMI (Target Vessel Myocardial Infarction)
Endpoint domain: Adverse events/effects
Primary endpoint: ST (Stent Thrombosis)
Endpoint domain: Adverse events/effects
Primary endpoint: Healthy food choices
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: OCT-evaluated stent strut coverage
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Overall cosmetic results
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Breast recurrence
Endpoint domain: Mortality/survival
Primary endpoint: Breast discomfort
Endpoint domain: Adverse events/effects
Primary endpoint: Cost-effectiveness of early medical abortion
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: superior vena cava blood flow
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: right ventricle output
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: right ventricular stroke volumes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Renal (15)N-excretion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Faecal (15)N-excretion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Urinary (15)NH(3)-enrichment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: hs-CRP concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Type and CFU of bacteria on the alveolar ridge mucosa
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Percentages of oral Streptococci and Neisseriae
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Total area under the curve for insulin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: General health
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Risk of fast ventricular tachycardia/ventricular fibrillation (VT/VF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Blood flow volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Specificity in the diagnostic gray zone
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sensitivity fixed at 96%
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Conscious control of movement during speech
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Response to therapy based on improvement of > or =1 NYHA class
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Vancomycin concentration in the anterior chamber
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pancreatic cyst resolution
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: recurrence of symptoms of appendicitis
Endpoint domain: Adverse events/effects
Primary endpoint: complication rate after appendectomy
Endpoint domain: Adverse events/effects
Primary endpoint: Average cumulative 24 h meperidine dose
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Postpartum hemorrhage amount
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Postpartum hemorrhage rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Subjective alertness
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Physical performances
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: run time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: number of exercise laps
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Expression of CTGF and TGF-beta mRNA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidence of biopsy-confirmed acute rejection
Endpoint domain: Mortality/survival
Primary endpoint: Mean number of oocytes retrieved
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Vickers hardness of enamel
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Post-training maximal walking time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Minimum lumen area
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Significant residual stenosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Significant edge dissection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: 30-day reinfarction rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: 30-day stent thrombosis rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Beta-cell function stability
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Half-life of infused fluid
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Urinary excretion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improvement in HUI3
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Improvement in SF‐6D
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Improvement in eQWB
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Reduced brain activity in response to food pictures
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Reduction in all ulcers
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Reduction in ulcer complications
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Monthly number of new prescriptions for ramipril
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Blood lactate values
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: improvement in median best corrected visual acuity (BCVA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Vertical orthopedic growth in the mandible
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction of falls
Endpoint domain: Adverse events/effects
Primary endpoint: Left ventricular end-systolic/diastolic diameter ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Interventricular septum/posterior wall thickness ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Shortening fraction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Visual field decay
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: relative change in systolic BP (SBP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Reduction of serum ECP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Reduction of eosinophils
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Reduction of interleukin-6 levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Reduction of tumor necrosis factor-α levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Reduction of inducible nitric oxide synthase production
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Reduction in time spent crying
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cried <3 hours/day
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Anastomotic stenosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: repair bond strength
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage change of external elastic membrane (EEM) areas
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Lung deposition of fenoterol
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Lung deposition of flunisolide
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Oropharyngeal deposition of fenoterol
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: ASES Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of retears
Endpoint domain: Adverse events/effects
Primary endpoint: Prescription of thiazide diuretics
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: excellent communication
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Dexterity impairment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Clinician-reported grade 1-4 adverse events of the nervous system
Endpoint domain: Adverse events/effects
Primary endpoint: Cognitive Functioning score
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Pitch memory and labelling
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Chord segmentation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cost-effectiveness of guided self-help
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Cost-effectiveness of supported cCBT
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: size-normalized clearance of dexmedetomidine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: post‐bronchodilator FEV1
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: hospitalised exacerbation rates
Endpoint domain: Adverse events/effects
Primary endpoint: Five-year disease-free interval
Endpoint domain: Mortality/survival
Primary endpoint: Toxicity (mucositis and conjunctivitis)
Endpoint domain: Adverse events/effects
Primary endpoint: Pain scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Left ventricular ejection fraction (LVEF) at 6 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Occurrence of severely depressed LVEF (≤35%) at 6 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Heart failure admission
Endpoint domain: Mortality/survival
Primary endpoint: Regional tidal volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Ventilation inhomogeneity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: frequent exposure to violence in the community
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: physical abuse during childhood/adolescence
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: sexual abuse
Endpoint domain: Adverse events/effects
Primary endpoint: baseline-adjusted peak glucose response
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: incremental area under the glucose curve
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: baseline-adjusted peak glucose concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Mean vessel density of the SVP, ICP, and DCP
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean FAZ area of the SVP, ICP, and DCP
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in SFA intake
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Ability to control myoelectric hand
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Learning abilities in producing distinct myoelectric signals
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Placebo-corrected increase in DBP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Endothelin-1 (ET-1) levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Detection of subclinical atrial fibrillation (AF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: PTSD symptom improvement
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Attention bias variability reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of ventricular and supraventricular tachycardia
Endpoint domain: Adverse events/effects
Primary endpoint: Magnesium level after arrival in CICU
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: short answer test score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: successful completion of airway maneuvers and vascular access
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: confidence in leadership role
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in UA concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Controlled hyperuricemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: New-onset hyperuricemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Average week-long experience of T2D symptoms and impacts
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Plantar pressure reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Accuracy of diagnostic procedures
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: steady peak concentration of carbamazepine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: trough concentration of carbamazepine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: area under the plasma concentration‐time curve of carbamazepine
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidence of invasive CMV infection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: breast-feeding initiation and duration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: self-efficacy in breast-feeding
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Health-related quality of life (HRQoL) impairment
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Physical functioning score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Bodily pain score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: REM density
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: slow-wave sleep (SWS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: sleep latency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: 24 h urine excretion of MTX
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Likelihood of writing up the surgeon
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Restoration of iron status
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Aortic arterial elasticity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: greater fat reduction at 12 months post-intervention
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: intra operative blood loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: operating theatre cost
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: area under the concentration‐time curve (AUClast)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: operative performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: fragmentation status of the BARs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pharmacokinetics of maraviroc
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes